These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 26043970)
1. Influenza vaccination in patients with end-stage renal disease. Principi N; Esposito S; Expert Opin Drug Saf; 2015 Aug; 14(8):1249-58. PubMed ID: 26043970 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination. Morelon E; Pouteil Noble C; Daoud S; Cahen R; Goujon-Henry C; Weber F; Laurent PE; Kaiserlian D; Nicolas JF Vaccine; 2010 Oct; 28(42):6885-90. PubMed ID: 20709000 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of influenza vaccination in children with asthma. Patria MF; Tenconi R; Esposito S Expert Rev Vaccines; 2012 Apr; 11(4):461-8. PubMed ID: 22551031 [TBL] [Abstract][Full Text] [Related]
4. Influenza vaccination in immunocompromised patients: efficacy and safety. Zbinden D; Manuel O Immunotherapy; 2014; 6(2):131-9. PubMed ID: 24491087 [TBL] [Abstract][Full Text] [Related]
5. Influenza immunization in hemodialyzed or kidney transplanted adolescents and young adults. Esposito S; Mastrolia MV; Ghio L; Paglialonga F; Terranova L; Scala A; Edefonti A; Principi N Expert Rev Vaccines; 2014 Aug; 13(8):1059-66. PubMed ID: 24972949 [TBL] [Abstract][Full Text] [Related]
6. Influenza vaccine delivery and effectiveness in end-stage renal disease. Gilbertson DT; Unruh M; McBean AM; Kausz AT; Snyder JJ; Collins AJ Kidney Int; 2003 Feb; 63(2):738-43. PubMed ID: 12631142 [TBL] [Abstract][Full Text] [Related]
7. Translating vaccine policy into action: a report from the Bill & Melinda Gates Foundation Consultation on the prevention of maternal and early infant influenza in resource-limited settings. Ortiz JR; Neuzil KM; Ahonkhai VI; Gellin BG; Salisbury DM; Read JS; Adegbola RA; Abramson JS Vaccine; 2012 Nov; 30(50):7134-40. PubMed ID: 23026690 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of influenza vaccination in children: European perspective. Heikkinen T; Heinonen S Vaccine; 2011 Oct; 29(43):7529-34. PubMed ID: 21820481 [TBL] [Abstract][Full Text] [Related]
9. Influenza vaccination and fetal and neonatal outcomes. Fell DB; Dodds L; MacDonald NE; Allen VM; McNeil S Expert Rev Vaccines; 2013 Dec; 12(12):1417-30. PubMed ID: 24195480 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults. Hakim H; Allison KJ; Van De Velde LA; Li Y; Flynn PM; McCullers JA Vaccine; 2012 Jan; 30(5):879-85. PubMed ID: 22155630 [TBL] [Abstract][Full Text] [Related]
11. Different influenza vaccine formulations and adjuvants for childhood influenza vaccination. Esposito S; Principi N Vaccine; 2011 Oct; 29(43):7535-41. PubMed ID: 21820478 [TBL] [Abstract][Full Text] [Related]
12. Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial. McKittrick N; Frank I; Jacobson JM; White CJ; Kim D; Kappes R; DiGiorgio C; Kenney T; Boyer J; Tebas P Ann Intern Med; 2013 Jan; 158(1):19-26. PubMed ID: 23277897 [TBL] [Abstract][Full Text] [Related]
13. [Influenza vaccination of immunocompromised patients: safe and effective]. Opstelten W; Rimmelzwaan GF; van Essen GA; Bijlsma JW Ned Tijdschr Geneeskd; 2009; 153():A902. PubMed ID: 19857314 [TBL] [Abstract][Full Text] [Related]
14. Should expectant mothers be vaccinated against flu? A safety review. Loubet P; Kerneis S; Anselem O; Tsatsaris V; Goffinet F; Launay O Expert Opin Drug Saf; 2014 Dec; 13(12):1709-20. PubMed ID: 25363497 [TBL] [Abstract][Full Text] [Related]
15. Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease. Layton JB; McGrath LJ; Sahrmann JM; Ma Y; Dharnidharka VR; O'Neil C; Weber DJ; Butler AM Vaccine; 2020 Jul; 38(33):5178-5186. PubMed ID: 32565346 [TBL] [Abstract][Full Text] [Related]
16. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination. Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100 [TBL] [Abstract][Full Text] [Related]
17. Influenza vaccination coverage rate in children: reasons for a failure and how to go forward. Olivier CW Hum Vaccin Immunother; 2012 Jan; 8(1):107-18. PubMed ID: 22252000 [TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children. Vajo Z; Kosa L; Szilvasy I; Pauliny Z; Bartha K; Visontay I; Kis A; Tarjan I; Rozsa N; Jankovics I Pediatr Infect Dis J; 2008 Dec; 27(12):1052-6. PubMed ID: 18978514 [TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis. Elkayam O Clin Dev Immunol; 2006; 13(2-4):349-51. PubMed ID: 17162376 [TBL] [Abstract][Full Text] [Related]
20. Preliminary data on immunogenicity, safety and tolerability of trivalent inactivated influenza vaccine in children with inborn errors of metabolism at risk of decompensation. Esposito S; Salvini F; Menni F; Scala A; Salvatici E; Manzoni F; Riva E; Giovannini M; Principi N Vaccine; 2013 Oct; 31(45):5149-51. PubMed ID: 24012567 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]